Our planet is facing a major pandemic outbreak due to COVID-19 and health agencies are taking every measure to stop it. The COVID-19 virus has been named “SARS-CoV-2” (severe acute respiratory syndrome coronavirus 2) and the disease it causes has been named “Coronavirus Disease 2019” (COVID-19). The outbreak of the respiratory disease was first detected […]Read More
Shots: The InPen bolus calculator determines the user’s current glucose level and active insulin to calculate the amount of insulin still lowering glucose from previous bolus doses thus removing the conjecture from insulin dosing The new InPen offers users on fixed-dose or meal estimation therapy an advance solution to maintain blood glucose level and avoid […]Read More
The Medical Devices Conference was hosted by DIA India on 21st and 22nd February in collaboration with the Medical Technology Association of India (MTaI), AIC-AMTZ Medivalley Incubation Council and mDI Europa, is one of the largest gatherings of medical devices professionals in the region. The conference was focused on giving better insights into the challenges […]Read More
Shots: The CHMP’s positive opinion is based on P-III VISIBLE study assessing vedolizumab (SC) as maintenance therapy vs PBO in ~1000 patients with moderately to severely active UC & CD who achieved clinical response @6wks. following the 2doses of vedolizumab (IV) @0 & 2wks. EC will now review the CHMP’s positive opinion and if approved, […]Read More
Shots: GSK, Evotec, J&J, Otsuka, the Bill & Melinda Gates Medical Research Institute and its foundation have launched the ‘PAN-TB collaboration’ project to collaboratively accelerate the development of novel TB treatment regimens The global collaboration will focus on developing a new regimen with the drug candidates that demonstrated efficacy in its P-II studies with limited […]Read More
Shots: Fujifilm’s CAD EYE receives CE mark, backing the real-time detection of colonic polyps during colonoscopy utilizing AI, will be available with software EW10-EC01 and the compatible expansion unit EX-1 in combination with the ELUXEO 7000 system CAD EYE utilizes FUJIFILM’s REiLi AI technology and can perform complex segmentation of 2D/3D images, spot lesions & […]Read More
Shots: The approval is based on seven clinical studies including three of which were pivotal efficacy and safety studies in pain relief which involves assessing of ibuprofen (250 mg) + acetaminophen (500 mg) vs ibuprofen and acetaminophen monothx in patients with acute pain symptoms The study demonstrated that the FD combination achieved superior efficacy then […]Read More
Shots: Trutino to receive upfront, pre/ clinical milestones, regulatory and commercial milestones along with royalties on sales. Boehringer to get access for Trutino’s ODC platform to develop up to 3 new ODC cancer immunology candidates The focus of the agreement is to develop more tolerable & effective cytokine therapies for single-agent and novel combinations with […]Read More
The 12-month clinical validation study (NCT02453776) data demonstrated the reduction “switching” from lower cost infliximab to more expensive biologics by 66%. Also, similar studies are ongoing in 9 countries on 3 continents The results were already presented at ECCO, Copenhagen, Mar 2019 and DDW, San Diego, May 2019 and the Baysient pipeline includes CDS for […]Read More
Shots: Sangamo to receive $350 million upfront, including $125M license fee & $225M equity investment in Sangamo’s stock or ~24M shares at $9.21/share and is eligible to receive $2.37B as milestones along with royalties on sales of the therapies Biogen to get an exclusive WW right of ST-501 for tauopathies including AD, ST-502 for synucleinopathies […]Read More
Copyright ©2021 PharmaShots | Powered by Octavus Consulting
